文档介绍：2004年国内外医药市场发展状况
一. 全球医药市场增长缓慢
I. 国外市场发展状况
Global Pharmaceutical Sales, 1997 - 2004
Global Sales US$B
1997
1998
1999
2000
2001
2002
2003
2004
Total World Market (current US$)
289
297
332
357
387
426
493
550
Growth Over Previous Year (Constant US$)
7%
11%
10%
12%
9%
10%
7%
Pharmaceutical Sales by Region, 2004
World Audited Market
2004 Sales (US$B)
(2003)
% Global Sales
(2003)
% Growth Year-over-Year (2003)
North America
$248()
%(49)
%(9)
Europe (EU)
144()
(25)
(8)
Rest of Europe
9()
(3)
(14)
Japan
58()
(11)
(3)
Asia (excluding Japan), Africa and Australia
40()
(8)
(12)
Latin America
19()
(4)
(6)
Total IMS Audited*
$518
100%
%
Leading Therapy Classes by Global Pharmaceutical Sales, 2004
Audited World Therapy Class
2004 Sales
% Global Sales (US$)
% Growth Year-over-Year
1(1).
Cholesterol&Triglyceride
Reducers
$()
%(6)
%(14)
2.(2)
Antiulcerants
()
(5)
(9)
3.
Cytostatics
4.(3)
Antidepressants
()
(4)
(10)
5.(5)
Antipsychotics
()
(3)
(20)
6.(4)
Antirheumatic Non-Steroidals
()
(3)
(6)
7.
Angiotensin-II Inhibitors
8.(6)
Calcium Antagonists Plain
()
(2)
(2)
9.(7)
Erythropoietin Products
()
(2)
(16)
10(8).
Anti-Epileptics
()
(2)
(22)
Total Leading therapy classes*
$
%
%
Leading Products by Global Pharmaceutical Sales, 2004
Leading Brands
2004 Sales (US$B)
% Growth Year-over-Year
1.(1)
Lipitor阿伐他汀,辉
$()
%(14)
2.(2)
Zocor辛伐他汀
()
-(-4)
3(8)
Plavix***吡格雷
()
(40)
4. .(7)
Nexium (esomeprazole)
()
(62)
5.(3)
Zyprexa奥氮平
()
0(13)
6.(4)
Norvasc络活喜
()
(7)
7(9).
Seretide羟基酸沙美特罗
()
(40)
8.(5)
Erypo阿伐依泊汀
(4)
0(13)
9.(6)
Ogastro兰索拉唑
(4)
-(0)